Transcriptome Analysis and Machine Learning Prioritize Therapeutic Strategies for High-Risk Pediatric AML Patients of the KMT2A-Fusion Subgroup
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:3385-3386 - Subject
- Language
- ISSN
- 0006-4971